Oral Misoprostol Solution in Labor Induction

• Status: Unknown status
• Trial end date: 2020-01-18
• Target enrollment: 0
• Participant gender: Female

Summary

This study compares safety and efficacy between repetitive hourly dose of oral misoprostol and two hourly dose oral regimens for cervical ripening and labor induction.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• Nulliparas

• Term pregnancy(equal or more than 37 wks)

• Bishop score <6

• Cephalic presentation

• reassuring fetal heart rate pattern

• Not in labor ( no uterine contractions)

• Clinically adequate pelvis

• Singleton live pregnancy

Exclusion Criteria:

• Allergic to misoprostol or prostaglandin analogues

• Previous uterine scar( cesarean section,hysterotomy,myomectomy)

• Multiple fetal gestations

• Fetal demise

• Preterm labor

• Malpresentations

• Non reactive cardiotocography at admission

• Cephalo pelvic disproportion

• Fetal macrosomia